JP2024178283A5 - - Google Patents

Download PDF

Info

Publication number
JP2024178283A5
JP2024178283A5 JP2024161331A JP2024161331A JP2024178283A5 JP 2024178283 A5 JP2024178283 A5 JP 2024178283A5 JP 2024161331 A JP2024161331 A JP 2024161331A JP 2024161331 A JP2024161331 A JP 2024161331A JP 2024178283 A5 JP2024178283 A5 JP 2024178283A5
Authority
JP
Japan
Prior art keywords
antibody
tau protein
antibody conjugate
carrier
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024161331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024178283A (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/045589 external-priority patent/WO2020105700A1/ja
Application filed filed Critical
Publication of JP2024178283A publication Critical patent/JP2024178283A/ja
Publication of JP2024178283A5 publication Critical patent/JP2024178283A5/ja
Pending legal-status Critical Current

Links

JP2024161331A 2018-11-22 2024-09-18 抗体コンジュゲート Pending JP2024178283A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018219558 2018-11-22
JP2018219558 2018-11-22
PCT/JP2019/045589 WO2020105700A1 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート
JP2020557617A JP7594913B2 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020557617A Division JP7594913B2 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート

Publications (2)

Publication Number Publication Date
JP2024178283A JP2024178283A (ja) 2024-12-24
JP2024178283A5 true JP2024178283A5 (cg-RX-API-DMAC7.html) 2025-03-28

Family

ID=70773827

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020557617A Active JP7594913B2 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート
JP2024161331A Pending JP2024178283A (ja) 2018-11-22 2024-09-18 抗体コンジュゲート

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020557617A Active JP7594913B2 (ja) 2018-11-22 2019-11-21 抗体コンジュゲート

Country Status (5)

Country Link
US (1) US20220018856A1 (cg-RX-API-DMAC7.html)
EP (1) EP3885362A4 (cg-RX-API-DMAC7.html)
JP (2) JP7594913B2 (cg-RX-API-DMAC7.html)
CN (1) CN113166235A (cg-RX-API-DMAC7.html)
WO (1) WO2020105700A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7718270B2 (ja) * 2019-09-30 2025-08-05 ニプロ株式会社 血液試料を検体とするタウタンパク質検出方法
CN113533746B (zh) * 2021-07-22 2022-05-10 深圳市天大生物医疗器械有限公司 一种P-Tau蛋白化学发光检测试剂盒及其制备方法
CA3231228A1 (en) 2021-09-09 2023-03-16 Andreas Jeromin Phospho-tau antibodies and methods of use
CN115015228A (zh) * 2022-02-22 2022-09-06 上海科华生物工程股份有限公司 一种检测血液中p-tau181蛋白的化学发光试剂盒及其制备方法
WO2026029079A1 (ja) * 2024-07-31 2026-02-05 富士レビオ株式会社 リン酸化タウタンパク質の測定方法およびリン酸化タウタンパク質の測定キット

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690092B2 (en) 1992-12-14 1998-04-23 N.V. Innogenetics S.A. Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
JPH06239899A (ja) * 1993-02-12 1994-08-30 Teijin Ltd ヒトタウ蛋白に対する抗体、並びに該抗体を利用する体液中のヒトタウ蛋白の測定方法
ATE335007T1 (de) 1993-12-21 2006-08-15 Innogenetics Nv Monoklonale antikörper gegen phf-tau, hybridomen die diese ausscheiden, antigenerkennung durch diesen antikörper und deren verwendungen
BR0107851A (pt) * 2000-01-24 2002-10-29 Innogenetics Nv Diagnose de tauopatia
US7534427B2 (en) * 2002-12-31 2009-05-19 Immunomedics, Inc. Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
US20130095492A1 (en) 2010-03-05 2013-04-18 Albert Einstein College Of Medicine Of Yeshiva University Method of detecting tau protein and tau fragments in serum
GB201112056D0 (en) * 2011-07-14 2011-08-31 Univ Leuven Kath Antibodies
EP3275461A1 (en) * 2011-09-19 2018-01-31 Axon Neuroscience SE Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease field
WO2014011972A1 (en) * 2012-07-13 2014-01-16 Bristol-Myers Squibb Company Tau immunoassay
EP3105251A4 (en) * 2014-02-10 2017-11-15 Merck Sharp & Dohme Corp. Antibodies that bind to human tau and assay for quantifying human tau using the antibodies
AU2016249404B2 (en) 2015-04-17 2021-01-21 Igm Biosciences, Inc. Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof

Similar Documents

Publication Publication Date Title
CN111704666B (zh) 新型冠状病毒n蛋白的配对单克隆抗体及其应用
CN104246504B (zh) A型流感病毒的检测试剂盒
CN112175072B (zh) 抗h5亚型禽流感病毒血凝素蛋白单克隆抗体zju5-01及其应用
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
JP2008503720A5 (cg-RX-API-DMAC7.html)
CN102816234A (zh) 肽、该肽的用途和生产方法以及固定有该肽的固相和其生产方法
CN112851803B (zh) 抗h10亚型禽流感病毒血凝素蛋白单克隆抗体zju10-01及其应用
CN1932517B (zh) 检测或确定hcv核心抗原的方法及其中应用的用于检测或确定的试剂
CN103045541A (zh) 杂交瘤细胞株及其产生的抗人心脏型脂肪酸结合蛋白的单克隆抗体
JPH04232462A (ja) アンギオテンシンiiの特異的検定のためのキット
CN101165491B (zh) 以金磁微粒为载体检测抗双链dna抗体的方法
CN110996986B (zh) Hcv抗原的多表位融合蛋白及其用途
JPH02253162A (ja) 特異的結合能を有する物質と結合したエクオリンを用いる検出法
JP2000002707A (ja) Env/gagポリペプチドマ―カ―を使用するネコ免疫不全ウイルス感染の診断
FR2717499A1 (fr) Fragments d'anticorps recombinants synthétisés et biotinylés dans E. coli, leur utilisation en immunodosages et en purification par immunoaffinité.
JP2837669B2 (ja) T−細胞リンパ趨行性ウイルス蛋白及びその分析
CN113563484B (zh) 一种G11-scFv-Nluc双功能活性的融合蛋白及其应用
CN109470855B (zh) 肺癌早期诊断用蛋白芯片及试剂盒
CN115932255A (zh) 一种山羊痘病毒抗体荧光微球免疫层析检测试剂盒及其制备方法
JPH01153960A (ja) 赤血球凝集アッセイ
CN112724249A (zh) 抗h9亚型禽流感病毒血凝素蛋白单克隆抗体zju9-01及其应用
CN121319195B (zh) 一种用于检测padi2的高亲和力抗体对及其应用
Lauritzen et al. Peptide dot immunoassay and immunoblotting: Electroblotting from aluminum thin‐layer chromatography plates and isoelectric focusing gels to activated nitrocellulose
WO2007056114B1 (en) Compositions and methods for the detection of trypanosoma cruzi infection
Jankovicova et al. Benefits of immunomagnetic separation for epitope identification in clinically important protein antigens: A case study using ovalbumin, carbonic anhydrase I and Tau protein